Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether metformin can increase urine concentration (osmolality) and decrease the amount of urine in patients with congenital nephrogenic diabetes insipidus (N...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Emory University
NCT07361263 · AVP Deficiency, Diabetes Insipidus
NCT06808516 · Arginine Vasopressin Deficiency, Central Diabetes Insipidus, and more
NCT06065852 · Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, and more
NCT07525960 · X-linked Congenital Nephrogenic Diabetes Insipidus
NCT05190744 · Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus, and more
Childen's Healthcare of Atlanta
Atlanta, Georgia
Emory University Hospital - Atlanta Clinical and Translational Science Institute (ACTSI)
Atlanta, Georgia
Emory University Hospital
Atlanta, Georgia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions